Allopurinol

CAS 315-30-0 22 current records 9 historicalSmall Molecule

Who holds supplier records for Allopurinol? 22 organisations hold a current record for Allopurinol: an active US FDA Type II Drug Master File or a CEP. A further 9 organisations have only historical (inactive) DMF filings. 20 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (13), China (2), Netherlands (1), Taiwan (1) and 3 other countries (3); not recorded for 2.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Allopurinol: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/allopurinol

Reading the evidence

  • 22 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • Most recorded organisations are in India

    13 of the 20 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.

  • 9 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (22)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Allopurinol. Country is the organisation's recorded country, not necessarily the manufacturing site.

Need Allopurinol sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (20)

Certificates of Suitability on the EDQM register for Allopurinol, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 28 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
ANHUI POLY PHARM. CO., LTD. AnqingCN
CEP 2024-410 - Rev 00
Allopurinol
Sept 2026—
HARMAN FINOCHEM LIMITED MumbaiIN
CEP 2001-433 - Rev 07
Allopurinol
Jul 2026—
EXEMED PHARMACEUTICALS VadodaraIN
CEP 2021-331 - Rev 02
Allopurinol
Jun 2026Inspected Feb 2025
Hungary
SUPRIYA LIFESCIENCE LIMITED MumbaiIN
CEP 2024-127 - Rev 00
Allopurinol
Jun 2026—
ASSURGEN PHARMA PRIVATE LIMITED VisakhapatnamIN
CEP 2022-390 - Rev 01
Allopurinol
Apr 2026Inspected May 2023
Hungary, outside 3-year window
HALEOS LABS LIMITED HyderabadIN
CEP 2021-239 - Rev 02
Allopurinol
Feb 2026—
ANUH PHARMA LTD. MumbaiIN
CEP 2023-078 - Rev 01
Allopurinol
Jan 2026—
HETERO DRUGS LIMITED HyderabadIN
CEP 2025-441 - Rev 00
Allopurinol, Site-II
Nov 2025—
MATRIX PHARMACORP PRIVATE LIMITED Sangareddy DistrictIN
CEP 2000-015 - Rev 08
Allopurinol
Oct 2025—
TAPI NL B.V. AmsterdamNL
CEP 1998-118 - Rev 08
Allopurinol
Jul 2025—
HENAN DONGTAI PHARM CO., LTD. AnyangCN
CEP 2023-232 - Rev 00
Allopurinol
Jun 2025—
IPCA LABORATORIES LIMITED MumbaiIN
CEP 2008-211 - Rev 05
Allopurinol
Jun 2025—
INDOCO REMEDIES LIMITED MumbaiIN
CEP 2008-017 - Rev 05
Allopurinol
Mar 2025—
SIGNA S.A. DE C.V. TolucaMX
CEP 2001-335 - Rev 04
Allopurinol
Jul 2024—
IOL CHEMICALS AND PHARMACEUTICALS LTD LudhianaIN
CEP 2023-029 - Rev 00
Allopurinol
Jun 2024—
EGIS Pharmaceuticals PLC BudapestHU
CEP 2014-364 - Rev 01
Allopurinol, Synthetic route B
Nov 2023Inspected Nov 2025
Hungary
SINBIOTIK S.A. DE C.V. Tlalnepantla de BazMX
R0-CEP 2022-070 - Rev 00
Allopurinol
Jul 2023—
STYRAX PHARMA PRIVATE LIMITED AnakapalliIN
R0-CEP 2022-119 - Rev 00
Allopurinol
Jun 2023—
Union Quimico Farmaceutica, S.A. (Uquifa S.A.) BarcelonaES
R1-CEP 2003-004 - Rev 02
Allopurinol
Dec 2017—
SCI Pharmtech, Inc. TaoyuanTW
R1-CEP 2002-164 - Rev 00
Allopurinol
Jan 2009—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (9)

Organisations whose Type II DMFs for Allopurinol are no longer active. These show a past filing, not current supply.

Show all 9 historical records
  • PKU HEALTHCARE CORP LTD
    Inactive DMF 23954 · filed Jul 2010
  • AXITEC CO LTD
    Inactive DMF 17855 · filed Oct 2004
  • LABORATORIO CHIMICO INTERNAZIONALE SPA
    Inactive DMF 15945 · filed Apr 2002
  • RHONE-POULENC SANTE INC
    Inactive DMF 6452 · filed Jul 1986
  • FABBRICA ITALIANA SINTETICI SPA
    Inactive DMF 6373 · filed May 1986
  • ORGAMOL SA
    Inactive DMF 5235 · filed Jan 1984
  • DIOSYNTH BV
    Inactive DMF 4950 · filed Feb 1983
  • SIEGFRIED AG
    Inactive DMF 3480 · filed Mar 1979
  • DINAMITE DIPHARMA SPA
    Inactive DMF 2534 · filed Oct 1975

Other forms of this substance

A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:

Overview

Allopurinol is a xanthine oxidase inhibitor that is primarily used to decrease uric acid levels in the blood. It is commonly prescribed to prevent gout flares and to manage tumor lysis syndrome during chemotherapy.

Chemical identity

IUPAC name
1,5-dihydropyrazolo[5,4-d]pyrimidin-4-one
Canonical SMILES
C1=NNC2=C1C(=O)NC=N2
InChIKey
OFCNXPDARWKPPY-UHFFFAOYSA-N
Synonyms
Zyloprim API, allopurinolum, bw 56-158, bw-56-158, duzallo component allopurinol, lopurin, nsc-101655, nsc-1390, suspendol, takanarumin, zyloprim

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Xanthine Oxidase Inhibitor
Mechanism of action
Xanthine Oxidase Inhibitors

Therapeutic areas

RheumatologyNephrologyUrology

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Allopurinol?

22 organisations hold an active US FDA Type II Drug Master File or a CEP for Allopurinol: TAPI NL BV (Netherlands), ANHUI POLY PHARM CO LTD (China), Exemed Pharmaceuticals (India), HALEOS LABS LTD (India), HARMAN FINOCHEM LTD (India), HENAN DONGTAI PHARM CO LTD (China), Hetero Drugs Limited (India) and INDOCO REMEDIES LTD (India), and 14 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Allopurinol Drug Master Files are active?

TAPI NL BV (DMF 2506, 2870), ANHUI POLY PHARM CO LTD (DMF 40108), Exemed Pharmaceuticals (DMF 36113), HALEOS LABS LTD (DMF 36130), HARMAN FINOCHEM LTD (DMF 17128), HENAN DONGTAI PHARM CO LTD (DMF 39797), Hetero Drugs Limited (DMF 35422) and INDOCO REMEDIES LTD (DMF 21239) and 8 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Allopurinol records mean?

9 organisations have only inactive Type II DMFs for Allopurinol. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Allopurinol have a European Certificate of Suitability?

Yes. 20 organisations hold a valid CEP for Allopurinol on the EDQM register, including ANHUI POLY PHARM. CO., LTD. Anqing (CN), HARMAN FINOCHEM LIMITED Mumbai (IN), EXEMED PHARMACEUTICALS Vadodara (IN), SUPRIYA LIFESCIENCE LIMITED Mumbai (IN), ASSURGEN PHARMA PRIVATE LIMITED Visakhapatnam (IN) and HALEOS LABS LIMITED Hyderabad (IN) and 14 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Allopurinol supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Allopurinol?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.